240 related articles for article (PubMed ID: 16045727)
21. Rheumatoid arthritis: targeting the proliferative fibroblasts.
Kramer I; Wibulswas A; Croft D; Genot E
Prog Cell Cycle Res; 2003; 5():59-70. PubMed ID: 14593701
[TBL] [Abstract][Full Text] [Related]
22. Rheumatoid arthritis progression mediated by activated synovial fibroblasts.
Neumann E; Lefèvre S; Zimmermann B; Gay S; Müller-Ladner U
Trends Mol Med; 2010 Oct; 16(10):458-68. PubMed ID: 20739221
[TBL] [Abstract][Full Text] [Related]
23. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.
van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
Thyroid; 2010 May; 20(5):535-44. PubMed ID: 20384487
[TBL] [Abstract][Full Text] [Related]
24. Fibroblast biology. Synovial fibroblasts in rheumatoid arthritis: leading role or chorus line?
Kontoyiannis D; Kollias G
Arthritis Res; 2000; 2(5):342-3. PubMed ID: 11094445
[No Abstract] [Full Text] [Related]
25. Autoimmunity in Graves' ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors?
Wiersinga WM
J Clin Endocrinol Metab; 2011 Aug; 96(8):2386-94. PubMed ID: 21677036
[TBL] [Abstract][Full Text] [Related]
26. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE; Tetlow LC
Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
[TBL] [Abstract][Full Text] [Related]
27. Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders.
Kuroki T; Ruf J; Whelan L; Miller A; Wall JR
Clin Exp Immunol; 1985 Nov; 62(2):361-70. PubMed ID: 3841305
[TBL] [Abstract][Full Text] [Related]
28. Retroocular fibroblasts: important effector cells in Graves' ophthalmopathy.
Bahn RS; Heufelder AE
Thyroid; 1992; 2(1):89-94. PubMed ID: 1525575
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic interventions targeting CD40L (CD154) and CD40: the opportunities and challenges.
Law CL; Grewal IS
Adv Exp Med Biol; 2009; 647():8-36. PubMed ID: 19760064
[TBL] [Abstract][Full Text] [Related]
30. Are there more than antibodies to the thyroid-stimulating hormone receptor that meet the eye in Graves' disease?
Drexhage HA
Endocrinology; 2006 Jan; 147(1):9-12. PubMed ID: 16365140
[No Abstract] [Full Text] [Related]
31. Antigen-presenting capacity of rheumatoid synovial fibroblasts.
Boots AM; Wimmers-Bertens AJ; Rijnders AW
Immunology; 1994 Jun; 82(2):268-74. PubMed ID: 7927499
[TBL] [Abstract][Full Text] [Related]
32. Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue.
Bradfield PF; Amft N; Vernon-Wilson E; Exley AE; Parsonage G; Rainger GE; Nash GB; Thomas AM; Simmons DL; Salmon M; Buckley CD
Arthritis Rheum; 2003 Sep; 48(9):2472-82. PubMed ID: 13130466
[TBL] [Abstract][Full Text] [Related]
33. Intracellular IL-1 alpha in fibroblasts as a possible endogenous mediator of joint damage in rheumatoid arthritis.
Apte RN
Isr J Med Sci; 1997 Apr; 33(4):285-8. PubMed ID: 9347881
[No Abstract] [Full Text] [Related]
34. Presentation of arthritogenic peptide to antigen-specific T cells by fibroblast-like synoviocytes.
Tran CN; Davis MJ; Tesmer LA; Endres JL; Motyl CD; Smuda C; Somers EC; Chung KC; Urquhart AG; Lundy SK; Kovats S; Fox DA
Arthritis Rheum; 2007 May; 56(5):1497-506. PubMed ID: 17469112
[TBL] [Abstract][Full Text] [Related]
35. The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway.
Toubi E; Shoenfeld Y
Autoimmunity; 2004; 37(6-7):457-64. PubMed ID: 15621572
[TBL] [Abstract][Full Text] [Related]
36. Immunotherapy targeting the CD40/CD154 costimulatory pathway for treatment of autoimmune disease.
Howard LM; Miller SD
Autoimmunity; 2004 Aug; 37(5):411-8. PubMed ID: 15621565
[TBL] [Abstract][Full Text] [Related]
37. The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis.
Noss EH; Brenner MB
Immunol Rev; 2008 Jun; 223():252-70. PubMed ID: 18613841
[TBL] [Abstract][Full Text] [Related]
38. Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis.
Yoshioka T; Nakajima A; Akiba H; Ishiwata T; Asano G; Yoshino S; Yagita H; Okumura K
Eur J Immunol; 2000 Oct; 30(10):2815-23. PubMed ID: 11069062
[TBL] [Abstract][Full Text] [Related]
39. Effects of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) on the expression of inflammatory cytokines and apoptosis induction in rheumatoid synovial fibroblasts and monocytes.
Ji JD; Cheon H; Jun JB; Choi SJ; Kim YR; Lee YH; Kim TH; Chae IJ; Song GG; Yoo DH; Kim SY; Sohn J
J Autoimmun; 2001 Nov; 17(3):215-21. PubMed ID: 11712859
[TBL] [Abstract][Full Text] [Related]
40. CD40 mediated activation of gingival and periodontal ligament fibroblasts.
Sempowski GD; Chess PR; Moretti AJ; Padilla J; Phipps RP; Blieden TM
J Periodontol; 1997 Mar; 68(3):284-92. PubMed ID: 9100204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
